Kiora Pharmaceuticals Reports Additional Clinical Data for KIO-301 Showing a Statistically Significant Increase in Brain Activity in the Visual Cortex in Patients with Retinitis Pigmentosa
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Wall St futures rise as yields, oil dip
- Oil slips as Mideast exports, G7 stockpile ease supply concerns
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| (NASDAQ: KPRX) | Delayed: 2.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.53 | 52 Week High | $ | |||
| Open | $2.53 | 52 Week Low | $ | |||
| Day High | $2.53 | P/E | N/A | |||
| Day Low | $2.53 | EPS | $ | |||
| Volume | 13 | |||||
